Celldex Therapeutics, Inc. (CLDX): Insider Trades and Fund Holdings
What insiders and tracked funds have reported about Celldex Therapeutics, Inc. in SEC filings.
Price today, live from TradingView. Values and changes on this page use our weekly prices (as of Oct 2), so trades line up with filings. Why
What the filings say about CLDX
There were no open-market insider trades at Celldex Therapeutics, Inc. in the past year. What the filings do show is who outside the company owns it.
1 fund we track reported CLDX in its latest 13F. The largest: Point72 Asset Management ($4.4 million, cut its position by 96%).
Investors owning 5% or more filed 1 Schedule 13D or 13G report on CLDX in the past year.
The stock fell 10.3% over the last three months of weekly prices.
Written from the filings listed under Sources at the end of this page. Not investment advice.
CLDX price, with every reported trade
▲ insider buy▼ insider sale● Congress■ fund● planned sale■ 5% stake at prices of Oct 2
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.
Daily chart and analysis
Live daily prices and indicators from TradingView. The chart above uses our weekly prices so trades line up with filings.
Buybacks and executive pay
| Year | CEO pay reported | CEO pay "actually paid" | Value of $100 invested |
|---|---|---|---|
| 2025 | $5.37M | $4.83M | n/a |
| 2024 | $9.23M | $76K | n/a |
| 2023 | $8.36M | $3.74M | n/a |
From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.
Tracked funds that report CLDX
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Point72 Asset Management | 117,217 | $4.36M | ▼ −96.4% |
5% owners
Schedule 13D (active owners) and 13G (passive owners) filed in the past year. All 5% stakes →
| Filed | Owner | Form | Stake |
|---|---|---|---|
| Oct 7 | FMR LLC +1 | 13G update | 10.7% |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →
Sources
- 13F: Point72 Asset Management, Q2 2026
- Schedule 13D/G: FMR LLC · filed 2026-10-07
All 0 Form 4 filings for CLDX are in the table above, each linked to the SEC.
About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.